Source link : https://www.newshealth.biz/health-news/tirzepatide-shortage-resolved-compounder-sues-fda-menopause-mistaken-as-dementia/
All doses of the diabetes and weight management injectable tirzepatide (Mounjaro, Zepbound) were taken off the FDA’s shortage list. (Reuters) This prompted a compounding group to sue the FDA for removing the drug from said list. (Reuters) Meanwhile, the agency clarified its policies on the legal restrictions for making copies of approved drugs for compounders. […]
Author : News Health
Publish date : 2024-10-08 16:28:50
Copyright for syndicated content belongs to the linked Source.
inHealth